Effects of deflazacort vs. methylprednisone: A randomized study in kidney transplant patients

Pediatric Nephrology

Volumn 22, Issue 5, 2007, Pages 734-741

  Ferraris, Jorge R ^a,b,d   Pasqualini, Titania ^a   Alonso, Guillermo ^a   Legal, Susana ^a   Sorroche, Patricia ^a   Galich, Ana M ^a   Jasper, Héctor ^c  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^d NONE   (Argentina)

Author keywords

Body growth; Bone mineral density; Deflazacort; Dyslipoproteinemia; Renal transplantation

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN; DEFLAZACORT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEPREDNISONE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SOMATOMEDIN C;

ANALYSIS OF VARIANCE; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY GROWTH; BODY HEIGHT; BONE DENSITY; BONE MINERAL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GROWTH RETARDATION; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; KIDNEY TRANSPLANTATION; LEAN BODY WEIGHT; LIPID STORAGE; LUMBAR SPINE; MAINTENANCE THERAPY; MALE; OBESITY; OSTEOLYSIS; PREPUBERTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; WEIGHT GAIN;

ADIPOSE TISSUE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; CHILD; CHOLESTEROL; CHOLESTEROL, LDL; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIPIDS; METHYLPREDNISOLONE; PREGNENEDIONES; PROSPECTIVE STUDIES;

EID: 34247859040     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0403-0     Document Type: Article

References (29)

1. Scudeletti M, Castagneta L, Imbimbo B, Puppo F, Pierri I, Indiveri F (1990) New glucocorticoids. Mechanism of immunological activity at cellular level in the clinical setting. Ann N Y Acad Sci 595:368-382
2. Markham A, Bryson HM (1995) Deflazacort. A review of its pharmacological properties and therapeutic efficacy. Drugs 50:317-333
3. Nathanson G, Pasqualucci GR, Redaelli P, Schiatti P, Selva D, Winters G (1969) Steroids possessing nitrogen atoms. V. Some pharmacological and physicochemical aspects of a new class of active corticoids (17α, 16α-d) oxazolino steroids. Steroids 13:365-381
4. Vignolo M, Milani S, Imbimbo B, Naselli A, Di Battista E, Piaggio G, Leveratto L, Morreale G, Sardella ML, Corsini M, Cerbello G, Barotto M, Benso L, Aicardi G (1991) Statural growth and skeletal maturation in rheumatic prepubertal children treated with a third generation glucocorticoid (Deflazacort) versus prednisone-An interim study. Clin Exp Rheumat 9(Suppl 6):41-45
5. Pagano G, Lombardi A, Ferraris GM, Imbimbo B, Cavallo-Perin P (1982) Acute effect of prednisone and deflazacort on glucose tolerance in prediabetic subjects. Eur J Clin Pharmacol 22:469-471
6. Bruno A, Cavallo-Perin P, Cassader M, Pagano G (1987) Deflazacort vs Prednisone: Effect on blood glucose control in insulin-treated diabetics. Arch Intern Med 147:679-680
7. Aicardi G, Milani S, Imbimbo B, Vignolo M, Di Battista E, Gusmano R, Terragna A, Cordone G, Cottafava F, Coppo R, Sernia O, Porcellini MG, Sardella ML, Barotto M, Benso L (1991) Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: An interin long-term analysis. Calcif Tissue Int 48:283-287
8. Ferraris JR, Faisntein-Day P, Gutman R, Granillo E, Ramirez J, Ruiz S, Pasqualini T (1992) Effect of therapy with a new glucocorticoids, deflazacort, on linear growth and growth hormone secretion after renal transplantation. J Pediatr 121:809-813
9. Ferraris JR, Pennisi P, Pasqualini T, Jasper H (1997) Effects of deflazacort immunosuppression on long-term growth and growth factors after renal transplantation. Pediatr Nephrol 11:322-324
10. Ferraris JR, Tambutti ML, Redal M, Ramirez JA, Carlin MC, Samaniego MC, Prigoshin N (1996) Immunosuppressive activity of deflazacort in pediatric renal transplantation. Transplantation 62:417-420
11. Ferraris JR, Sorroche P, Legal S, Oyhamburu J, Brandi P, Pasqualini T (1998) Effect of therapy with deflazacort on dyslipoproteinemia after pediatric renal transplantation. J Pediatr 133:533-536
12. Ferraris JR, Pasqualini T, Legal S, Sorroche P, Galich AM, Pennisi P, Domenech H, Jasper H, the Deflazacort Study Group (2000) Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. Pediatr Nephrol 14:682-688
13. Assandri A, Buniva G, Martinelli E, Perazzi A, Zerelli L (1984) Pharmacokinetics and metabolism of deflazacort in the rat, dog, monkey and mean. Adv Exp Med Biol 71:9-23
14. Legarraga H, Anigstein C, Di Candia A, Heinrich J, Krupitzky S, Machado O, Moreno H (2001) Guías para la evaluaciôn del crecimiento, 2 edición. Sociedad Argentina de Pediatría, Buenos Aires, pp 19-113
15. Cole TJ, Bellizi MC, Flegal KM, Dietz WT (2000) Establishing a standard definition for children overweight and obesity worldwide: International survey. BMJ 320:1240-1243
16. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502
17. Vuguin P, Saenger P, Dimartino-Nardi J (2001) Fasting glucose insulin ratio: A useful measure of insulin resistance in girls with premature adrenache. J Clin Endocrinol Metab 86:4615-4617
18. Elli A, Rivolta R, Di Palo FQ, Parenti M, Vergallo G, Palazzi P, Zafiropulu S, Abelli C, Zanussi (1993) A randomized trial of deflazacort versus 6-methylprednisolone in renal transplantation immunosuppressive activity and side effects. Transplantation 5:205-212
19. Fine R (1993) Corticosteroids and growth. Kidney Int 44(Suppl 43):S-59-S-63
20. Ferraris J, Pasqualini T, Gutman R, Ramirez J, Faisntein-Day P (1997) Growth hormone-insulin like growth factor-I (IGF-I) axis in prepubertal children with chronic renal failure. J Pediatr Endocrinol Metab 10:19-25
21. Coirini H, Flores D, Vega CM, Gonzalez Deviselle ML, De Nicola AF (1994) Binding of the anti-inflammatory steroid deflazacort to glucocorticoid receptors in brain and peripheral tissues. In vivo A-D in vitro studies. J Steroids Biochem Molec Biol 49:43-49
22. Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607
23. Lippuner K, Casez JP, Horber FF, Jaeger P (1998) Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: A randomized, double blind study in kidney transplant patients. J Clin Endocrinol Metab 83:3795-3802
24. Scharer K, Feneberg R, Klaus G, Paschen C, Wuster C, Mehls O, Schaefer F (2000) Experience with deflazacort in children and adolescents after renal transplantation. Pediatr Nephrol 14:457-463
25. Guerrero R, de la Piedra C, Texeiro E, Bragado R, Traba ML (2004) Hydrocortisone and deflazacort induce different effects on Vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells. J Rheumatol 31:167-172
26. Sarwal M (2006) Steroid elimination is coming of age. Pediatr Nephrol 21:2-4
27. Marks SD, Trompeter RS (2006) Steroid preservation: The rationale to continued prescribing. Pediatr Nephrol 21:305-307
28. Höcker B, John U, Plank C, Wühl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tönshoff B (2004) Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: Results after four years. Transplantation 78:228-234
29. Scudeletti M, Castagneta L, Imbimbo B, Puppo F, Pierri I, Indiveri F (1990) New glucocorticoids. Mechanism of immunological activity at cellular level in the clinical setting. Ann N Y Acad Sci 595:368-382